HBV continuum of care using community- and hospital-based screening interventions in Senegal: Results from the PROLIFICA programme.
Sow A, Lemoine M, Toure PS, Diop M, Lo G, De Veiga J, Pape OT, Seck K, Ndow G, Bojang L, Kane A, Oudiane M, Howell J, Nayagam S, Moutchia J, Chemin I, Mendy M, Toure-Kane C, Thursz M, Ka M, Shimakawa Y, Mboup S
Impact of COVID-19 lockdown restrictions on hepatitis C testing in Australian primary care services providing care for people who inject drugs.
Traeger MW, van Santen DK, Sacks-Davis R, Asselin J, Carter A, Doyle JS, Pedrana A, Wilkinson AL, Howell J, Thatcher R, Didlick J, Donovan B, Guy R, Hellard ME, Stoové MA, Australia Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmissible Infections and Blood Borne Viruses (ACCESS)
COVID-19 Hepatitis C Injecting Drug UseRole of COVID-19 vaccine education in discharge planning to increase community vaccination coverage.
Tse WC, Fahey J, Doyle J, Hellard M, Howell J
COVID-19The Global Impact of Hepatitis B Vaccination on Hepatocellular Carcinoma.
Flores JE, Thompson AJ, Ryan M, Howell J
Hepatitis B